This week in transparency news: May 11 – May 17, 2019

by Staff writer,
Posted on 5/17/2019

Transparency in clinical trials is continually changing, and to stay on top of the news, TrialAssure brings a weekly round-up of some of the key stories surrounding disclosures in clinical trials. This week’s stories are as follows:

Transparency: What’s next for the healthcare industry? – MedTech Views

Pascale Schmidt, Compliance Officer at Roche Diagnostics International, and Kurt Seiler, Head of Compliance Roche Diabetes Care, discuss how Europe is taking steps to ensure transparency in the healthcare industry. Most notably, European healthcare companies have adopted a Code of Ethical Business that bans a direct sponsorship of health professionals. Additionally, all grants and financial support are subject to disclosure on a Europe-wide platform.

Read the full article on MedTech Views

 What makes today’s CIOs tick? A conversation with Mohamad Zahreddine, CIO of TrialAssureIDG Connect

TrialAssure CIO Mohamad Zahreddine discusses the evolving role of the modern CIO. When CIOs are true stakeholders in the organization, Mohamad adds, they are much more effective from an operational standpoint.

Learn more about Mohamad’s thoughts via IDG Connect

Event alert: TrialAssure attending Amsterdam conference, schedule your 1×1 – TrialAssure

Alan Nicolle, Director, EU Operations & Business Development and Don McLean, MBA, Sr. Manager of Global Marketing and Communications and will be attending CBI’s 8th Annual Publication and Clinical Trial Transparency Summit in June. Contact us to set up a 1×1!

View the conference agenda here

Share: